Group 1 - Guangkang Biotech (300804.SZ) announced that specific shareholders, including Qiongcheng Huatuo Zhiying No. 2 Investment Partnership (Limited Partnership), Shenzhen Huatuo Zhiyuan No. 3 Investment Enterprise (Limited Partnership), and Qiongcheng Ruihong Kaiyin No. 1 Equity Investment Fund Partnership (Limited Partnership), plan to reduce their holdings in the company within three months from the date of the announcement [1] - Huatuo Zhiying No. 2 and Huatuo Zhiyuan No. 3 plan to collectively reduce their holdings by no more than 1.3198 million shares, which accounts for 1.7835% of the company's total share capital [1] - Ruihong Kaiyin No. 1 plans to reduce its holdings by no more than 1.98 million shares, representing 2.6757% of the company's total share capital [1]
广康生化特定股东拟减持减持合计不超4.4592%股份